The HCV Test is a diagnostic tool designed for the accurate and rapid detection of the Hepatitis C Virus (HCV), a leading cause of liver disease worldwide. This test plays a crucial role in early diagnosis, enabling timely medical intervention and reducing the risk of chronic liver conditions, including cirrhosis and hepatocellular carcinoma.
Key Features:
High Sensitivity & Specificity: Utilizes advanced immunoassay or molecular techniques (ELISA, Rapid Tests, or PCR) to ensure reliable detection of HCV antibodies or viral RNA.
Multiple Formats Available: Includes laboratory-based tests (ELISA, Chemiluminescence) for high-throughput screening and rapid tests (lateral flow assays) for point-of-care (POC) use.
Fast Results: Rapid tests deliver results in 10–20 minutes, ideal for emergency screenings and remote settings.
Easy to Use: Minimal training required, with clear instructions for healthcare professionals and self-testing (where applicable).
CE Prequalification: Complies with international quality standards for safety and accuracy.
Benefits:
Early Detection: Facilitates prompt treatment with antiviral therapies (e.g., DAA drugs), improving patient outcomes.
Cost-Effective: Reduces long-term healthcare burdens by preventing advanced liver disease.
Portable & Scalable: Suitable for low-resource settings with limited lab infrastructure.
The HCV Test is an essential tool
| HCV Hepatitis C Virus Ab Test Strip | WB/S/P | Strip | 50T |
| HCV Hepatitis C Virus Ab Test Cassette | WB/S/P | Cassette | 25T |
High Sensitivity and Specificity – Modern HCV tests deliver exceptional accuracy, minimizing false positives and negatives. Advanced immunoassays and nucleic acid tests (NAT) ensure reliable detection of HCV antibodies, antigens, and RNA.
Rapid Results – Many HCV tests provide results in 20–30 minutes, enabling quick diagnosis and timely intervention. Rapid test kits are ideal for point-of-care (POC) settings with limited lab infrastructure.
Multiple Testing Methods – HCV diagnostics include:
ELISA/CLIA for antibody/antigen screening
PCR-based NAT for viral load quantification
Rapid lateral flow assays for decentralized testing
Automation Compatibility – Automated platforms (e.g., chemiluminescence analyzers) enhance throughput, reduce human error, and standardize results for high-volume labs.
Early Detection Capability – Fourth-generation ELISA tests detect both HCV antibodies and core antigens, shortening the window period post-infection compared to antibody-only assays.
Genotyping Options – Specialized PCR tests identify HCV genotypes (1–6), guiding personalized treatment strategies.
User-Friendly Design – Rapid tests feature simple procedures (fingerstick blood/serum/plasma), requiring minimal training—ideal for resource-limited areas.
Regulatory Compliance – Tests adhere to WHO, FDA, and CE standards, ensuring global acceptability.
Cost-Effectiveness – Scalable solutions cater to diverse budgets, from low-cost rapid kits to high-precision automated systems.
Dual/Multipanel Testing – Some assays integrate HCV with HIV/HBV screening, streamlining co-infection detection.
1. Sample Collection & Preparation
Specimen Types: Serum, plasma (EDTA), or whole blood
Collection:
Draw 3-5 mL venous blood in serum separator tube (for ELISA/CLIA)
For fingerstick samples (rapid test), wipe away first blood drop, collect second drop
Processing:
Centrifuge at 3000 rpm for 10 min (serum/plasma)
Avoid repeated freeze-thaw cycles
2. Test Procedure
A. Rapid Test (Lateral Flow)
Bring test device to room temperature (15-30°C)
Add 50μL serum/plasma or 3 drops whole blood to sample port
Immediately add 2 drops buffer
Read results at 20 minutes (maximum)
B. ELISA Method
Load 100μL samples/controls into anti-HCV coated wells
Incubate 60 min at 37°C
Wash 5× with 300μL wash buffer
Add 100μL enzyme conjugate, incubate 30 min
Repeat wash, add 100μL TMB substrate
Stop with 50μL stop solution after 15 min
Read at 450/620nm
C. PCR Testing
Extract RNA using viral RNA kit
Prepare PCR mix:
10μL RNA template
15μL master mix (primers/probes)
Run real-time PCR:
Reverse transcription: 50°C for 15 min
Amplification: 40 cycles of 95°C/15 sec → 60°C/1 min
3. Result Interpretation
Rapid Test:
Positive: Both control (C) and test (T) lines
Negative: Only control line
Invalid: No control line → repeat
ELISA:
Calculate cutoff value (NC mean + 0.6)
Sample OD ≥ cutoff = Reactive
PCR:
Positive: Ct ≤40 with proper curve shape
Negative: No amplification or Ct >40
4. Quality Control
Run positive/negative controls with each batch
For PCR: Include internal control in each sample
Document all QC data
Note: Always follow manufacturer's instructions for specific test kits. Store reagents as specified.
Clinical Diagnostics
Blood Donation Screening
Public Health Programs
Home Testing
Want to Get More Details About JCMED Medical Consumables?
We're waiting for your contact!